At the same time as researchers seek for biomarkers to predict ketamine reaction, clinicians find by themselves with a conundrum: Which patients need to start with IV ketamine, and which with Spravato? And exactly how do The 2 compare head to head in genuine response to treatment? Check out ccfcme.org/NIpodcast6 https://antoniog454aoc1.ltfblog.com/profile